Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis. [PDF]
Stankovic B +11 more
europepmc +1 more source
Evaluating the Predictive Value of Clinical Factors for Pembrolizumab Efficacy and Safety in Advanced NSCLC with High PD-L1 Expression (TPS ≥ 50%). [PDF]
Djordjevic F +5 more
europepmc +1 more source
Selecting Tolerant Maize Hybrids Using Factor Analytic Models and Environmental Covariates as Drought Stress Indicators. [PDF]
Stepinac D +11 more
europepmc +1 more source
Degenerative Changes in MCP/MTP Joints of Working Horses Without Lameness: Integrating CT-Based Assessment and Synovial Fluid Biomarkers. [PDF]
Marković L +5 more
europepmc +1 more source
Protocol for the process evaluation of a randomised clinical trial of incremental-start versus conventional haemodialysis: the TwoPlus study. [PDF]
Murea M +26 more
europepmc +1 more source
Description of unilateral kidney embolism and contralateral nephrectomy as a less invasive remnant kidney model in cats; a proof-of-concept study. [PDF]
Schmiedt CW +7 more
europepmc +1 more source
Association of circulating levels of anti-CarP antibodies with disease activity, disability and radiological damage in rheumatoid arthritis patients: an open-label, observational study. [PDF]
Markovic M +9 more
europepmc +1 more source
The effects of plyometric training on athletic' jump performance: a systematic review and meta-analysis. [PDF]
Ma S +5 more
europepmc +1 more source
Inclusive and sustainable active mobility: recommendations for older adults in Montenegro. [PDF]
Popovic S +2 more
europepmc +1 more source
Biologic Mechanisms Underlying the Heterogeneous Response to Tight Glycemic Control among Differentially Inflamed Patients in the HALF-PINT Trial. [PDF]
Zinter MS +14 more
europepmc +1 more source

